Josh Riggs
President and CEO
Replay available
Oncocyte Corporation (OCX) Q3 2024 Earnings Call
Oncocyte Corporation (NASDAQ: OCX) Q3 2024 earnings conference call, held 2024-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Eke Schutz
Chief Science Officer
Andrea James
CFO
Julie Silber
Senior Managing Director, PCG Advisory
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Insight Molecular Diagnostics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.035 Thank you for standing by. My name is Kayla and I will be your conference operator today. 00:00:04.035 -- 00:00:09.081 At this time, I'd like to welcome everyone to the OncoSite third quarter 00:00:09.081 -- 00:00:14.406 2024 earnings conference call. All lines have been placed on mute to prevent 00:00:14.406 -- 00:00:16.549 any background noise. 00:00:16.549 -- 00:00:19.632 After the speaker's remarks, there will be a question and answer session. 00:00:19.632 -- 00:00:24.537 If you'd like to ask a question during this time, simply press star followed by the number 00:00:24.537 -- 00:00:29.534 one on your telephone keypad. If you'd like to withdraw your question, again, press the 00:00:29.534 -- 00:00:34.880 star and 1. I would now like to turn the call over to Julie Silber, Senior 00:00:34.880 -- 00:00:38.464 Managing Director of PCG Advisory. You may begin. 00:00:38.464 -- 00:00:40.246 Thank 00:00:40.246 -- 00:00:45.453 you, Kayla. And thank you, everyone, for joining us for today's conference call to discuss 00:00:45.453 -- 00:00:48.376 OncoSite's third quarter 2024 00:00:48.376 -- 00:00:52.613 financial results and recent operating highlights. 00:00:52.613 -- 00:00:57.621 If you have not seen today's shareholder letter, please visit Oncocyte's investor relations 00:00:57.621 -- 00:01:01.143 page at investors.oncocyte.com 00:01:01.887 -- 00:01:06.995 to read it. Today's prepared remarks build upon the information that was already shared 00:01:06.995 -- 00:01:12.042 in this robust letter. On today's call is Oncocyte's 00:01:12.042 -- 00:01:17.230 President and CEO, Josh Riggs, Chief Science Officer, Eke Schutz, 00:01:17.230 -- 00:01:22.233 and CFO, Andrea James. before turning the call over to josh i'd 00:01:22.233 -- 00:01:27.13...